Philip Cohen

3.2k total citations
78 papers, 2.3k citations indexed

About

Philip Cohen is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Philip Cohen has authored 78 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 10 papers in Genetics. Recurrent topics in Philip Cohen's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Treatment and Pharmacology (5 papers). Philip Cohen is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Treatment and Pharmacology (5 papers). Philip Cohen collaborates with scholars based in United States, Canada and Israel. Philip Cohen's co-authors include Bruce D. Cheson, Richard H. van der Jagt, Katherine Robinson, Michael E. Williams, Jordan A. Herst, Anil Tulpule, Bernard Lemieux, Lee S. Schwartzberg, S A Rosenberg and Robert Warren and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Philip Cohen

73 papers receiving 2.1k citations

Peers

Countries citing papers authored by Philip Cohen

Since Specialization

Citations

This map shows the geographic impact of Philip Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cohen more than expected).

Fields of papers citing papers by Philip Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cohen. The network helps show where Philip Cohen may publish in the future.

Co-authorship network of co-authors of Philip Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Cohen. A scholar is included among the top collaborators of Philip Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Cohen. Philip Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dimethyl sulfoxide (DMSO): a solvent that may solve selected cutaneous clinical challenges 2022 ·Archives of Dermatological Research ·(unknown), (unknown), Robert A. Schwartz, Philip Cohen	17
2	Implementation of the Best Practice Clinical Learning Environment Framework: A case study for improving learning in the clinical setting using a novel quality improvement approach 2018 ·Donna Cohén, Philip Cohen, (unknown), (unknown), (unknown), (unknown)	2
3	Facial bacterial infections: Folliculitis 2014 ·Clinics in Dermatology ·(unknown), Robert A. Schwartz, Philip Cohen	29
4	Flexural and extensoral eruptions in dermatologic disease 2011 ·Clinics in Dermatology ·Zain Husain, Philip Cohen, Robert A. Schwartz, W. Clark Lambert	3
5	Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer 2010 ·Breast Cancer Research and Treatment ·Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, Mary Wilkinson, Yvonne Ottaviano, Gina G. Chung, Robert Warren, Jennifer Eng‐Wong, Philip Cohen, Karen L. Smith, Karen Creswell, (unknown), Rebecca Slack	29
6	Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma 2008 ·Journal of Clinical Oncology ·Katherine Robinson, Michael E. Williams, Richard H. van der Jagt, Philip Cohen, Jordan A. Herst, Anil Tulpule, Lee S. Schwartzberg, Bernard Lemieux, Bruce D. Cheson	250
7	Primary Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Occurring in the Rectum: A Case Report and Review of the Literature 2006 ·Southern Medical Journal ·Sushil Ahlawat, Yonca Kanber, (unknown), Metin Özdemirli, Philip Cohen, Stanley B. Benjamin, Nadim Haddad	34
8	Phase II Results of Bendamustine in Combination with Rituximab in Relapsed Indolent and Mantle-Cell Non-Hodgkin’s Lymphoma. 2006 ·Blood ·Richard H. van der Jagt, Philip Cohen, Bruce D. Cheson, Anil Tulpule, Jordan A. Herst, Bernard Lemieux, Lee S. Schwartzberg, Katherine Robinson, Jennifer Oliver, Michael E. Williams	6
9	Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum 2005 ·Gastrointestinal Endoscopy ·Sushil Ahlawat, Nadim Haddad, Yonca Kanber, Philip Cohen, Metin Özdemirli, Stanley B. Benjamin	6
10	Children of the revolution 1997 ·Philip Cohen	1
11	The cultural achievements of Bosnian Muslims 1997 ·ISLAMIC STUDIES ·(unknown), (unknown), (unknown), Kemal H. Karpat, (unknown), Selçuk Akşin Somel, Xavier Bougarel, Philip Cohen, (unknown), (unknown)	1
12	Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. 1996 ·Journal of Clinical Oncology ·Parkash S. Gill, J Wernz, David T. Scadden, Philip Cohen, Geoffrey Mukwaya, Jamie H. Von Roenn, Max Jacobs, Sanford Kempin, Ivan Silverberg, (unknown), Mark U. Rarick, A. Myers, F. Shepherd, C. Sawka, Malcolm C. Pike, Michael E. Ross	319
13	Bilateral spontaneous pneumothorax as the presenting feature in lymphangioleiomyomatosis 1995 ·Respiratory Medicine ·Neville Berkman, (unknown), Philip Cohen, E Deviri, (unknown), (unknown), M.R. Kramer	9
14	Ending the War and Securing Peace in Former Yugoslavia 1994 ·Pace international law review ·Philip Cohen	1
15	Murine epidermal Langerhans cells and splenic dendritic cells present tumor‐associated antigens to primed T cells 1994 ·European Journal of Immunology ·Philip Cohen, Peter A. Cohen, S A Rosenberg, James J. Mulé, (unknown)	93
16	Cultured Human Langerhans Cells Process and Present Intact Protein Antigens 1992 ·Journal of Investigative Dermatology ·Philip Cohen, Stephen I. Katz	23
17	The Muir-Torre Syndrome: A Disease of Sebaceous and Colonic Neoplasms 1989 ·Dermatology ·Robert A. Schwartz, David Goldberg, (unknown), (unknown), (unknown), Ahmad Najem, Philip Cohen	34
18	Miscellaneous cancers associated with AIDS 1989 ·Current Opinion in Oncology ·Philip Cohen	6
19	Immunopathological changes after multiple spider bites 1987 ·Contact Dermatitis ·(unknown), Robert Y. Lin, (unknown), Philip Cohen, Robert A. Schwartz	4
20	The Influence on Survival of Season of Onset of Childhood Acute Lymphoblastic Leukemia (All) 1987 ·Chronobiology International ·Philip Cohen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact